Skip to Main Content

Paper Details

Cost-effectiveness of adjuvant systemic therapies for patients with high-risk melanoma in Europe: a model-based economic evaluation.
ESMO Open
8
2021
Author NameAffiliation
Stefan SleijferErasmus MC Cancer Institute
  • 1 - 1

Datasets

Release 1.2